相关实验视频
Updated: Jun 28, 2025

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
6.6K
减肥手术及其对血清尿酸水平的代谢回声效应
Subodh Bashyal1, Shen Qu1,2,3, Manoj Karki4
1Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, CHN.
Cureus
|April 15, 2024
概括
腹腔外科手术显著降低血清尿酸 (SUA) 水平,提供超越减肥的代谢益处. 本综述探讨了手术干预如何影响SUA和高尿血管理.
科学领域:
- 代谢手术 代谢手术
- 肥胖医学 肥胖医学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 腹腔外科手术 (BS) 是对肥胖的主要干预措施,可显著减轻体重.
- 代谢手术解决与肥胖相关的代谢功能障碍,BS显示与血清尿酸 (SUA) 水平降低有一致的关联.
- 超尿血是肥胖中常见的并发症,与各种健康问题有关.
研究的目的:
- 审查目前关于减肥手术对血清尿酸水平影响的文献.
- 分析减肥手术后SUA变化的程度和时间.
- 了解BS在管理高尿血和相关疾病中的代谢优势.
主要方法:
- 在PubMed,谷歌学者,JAMA和科克兰图书馆的综合文献搜索,直到2024年2月1日.
- 对重点关注减肥手术和血清尿酸水平的研究进行分析.
- 对影响术后SUA减少的因素的综述.
主要成果:
- 腹腔外科手术始终导致血清尿酸水平降低.
- 减少SUA的时间和程度因手术程序而异.
- 观察到的SUA下降与功能,胰岛素敏感性和炎症标志物的改善有关.
结论:
- 腹腔外科手术是一种有效的策略,用于管理肥胖个体的高尿血症.
- BS的代谢益处延伸到改善SUA水平和降低相关疾病的风险.
- 进一步的研究可以阐明驱动SUA减少的特定机制,在不同的减肥手术后.
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
299
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
299
Hepatic Drug Excretion: Influencing Factors
127
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
127
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
174
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
174
Oral Hypoglycemic Agents: Biguanides and Glitazones
195
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
195
Antihypertensive Drugs: Action of Diuretics
679
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
679
Phase II Reactions: Glucuronidation
405
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
405

